News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,931 Results
Type
Article (14026)
Company Profile (304)
Press Release (248601)
Section
Business (79409)
Career Advice (152)
Deals (13206)
Drug Delivery (34)
Drug Development (50361)
Employer Resources (31)
FDA (5691)
Job Trends (5120)
News (144217)
Policy (10022)
Tag
Academia (902)
Alliances (21581)
Alzheimer's disease (779)
Antibody-drug conjugate (ADC) (65)
Approvals (5679)
Artificial intelligence (80)
Bankruptcy (99)
Best Places to Work (4541)
Biotechnology (249)
Breast cancer (121)
Cancer (1003)
Cardiovascular disease (83)
Career advice (132)
CAR-T (82)
Cell therapy (241)
Clinical research (40338)
Collaboration (375)
Compensation (152)
COVID-19 (1015)
C-suite (99)
Cystic fibrosis (72)
Data (1048)
Diabetes (95)
Diagnostics (1217)
Earnings (29050)
Events (47381)
Executive appointments (302)
FDA (6118)
Funding (361)
Gene editing (70)
Gene therapy (180)
GLP-1 (328)
Government (1067)
Healthcare (6559)
Infectious disease (1056)
Inflammatory bowel disease (100)
IPO (7218)
Job creations (859)
Job search strategy (127)
Layoffs (191)
Legal (1377)
Lung cancer (146)
Lymphoma (63)
Manufacturing (91)
Medical device (2566)
Medtech (2567)
Mergers & acquisitions (6170)
Metabolic disorders (286)
Neuroscience (1059)
NextGen: Class of 2025 (2013)
Non-profit (850)
Northern California (1202)
Obesity (156)
Opinion (93)
Parkinson's disease (82)
Patents (68)
People (25228)
Phase I (14234)
Phase II (18754)
Phase III (11869)
Pipeline (447)
Postmarket research (851)
Preclinical (5979)
Radiopharmaceuticals (207)
Rare diseases (222)
Real estate (1411)
Regulatory (8353)
Research institute (932)
Series A (71)
Southern California (1080)
Startups (1967)
United States (9521)
Vaccines (174)
Weight loss (92)
Date
Today (76)
Last 7 days (223)
Last 30 days (1160)
Last 365 days (20419)
2025 (1044)
2024 (20578)
2023 (22415)
2022 (26823)
2021 (27805)
2020 (23362)
2019 (16231)
2018 (11741)
2017 (13750)
2016 (11844)
2015 (14352)
2014 (10394)
2013 (7484)
2012 (7532)
2011 (7617)
2010 (7428)
Location
Africa (146)
Asia (17028)
Australia (2871)
California (2737)
Canada (870)
China (248)
Colorado (101)
Connecticut (116)
Europe (36604)
Florida (306)
Georgia (79)
Illinois (169)
Indiana (67)
Maryland (365)
Massachusetts (2175)
Minnesota (111)
New Jersey (675)
New York (751)
North Carolina (443)
Northern California (1202)
Ohio (88)
Pennsylvania (524)
South America (207)
Southern California (1080)
Texas (307)
Washington State (266)
262,931 Results for "hoth therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Applications
January 21, 2025
·
4 min read
Press Releases
Hoth Therapeutics Board of Directors Approves Bitcoin as Treasury Reserve Asset
November 20, 2024
·
4 min read
Press Releases
Hoth Therapeutics Achieves Breakthrough in Phase 2a Trial: HT-001 Delivers 100% Success in Combating Cancer Treatment Skin Toxicities
January 7, 2025
·
5 min read
Pharm Country
Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024
Hoth Therapeutics, Inc. is scheduled to attend the EF Hutton Annual Global Conference in New York, NY.
May 1, 2024
·
1 min read
Pharm Country
Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug Discovery
Hoth Therapeutics, Inc., a patient focused biopharmaceutical company, announced the entry into a joint development agreement with Wise Systems International SRL to leverage artificial intelligence utilizing the BioNeMo AI platform of Nvidia.
June 10, 2024
·
2 min read
Pharm Country
Hoth Therapeutics’ Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, is excited to announce a significant breakthrough by its subsidiary, Merveille.ai, in the field of obesity treatment.
March 27, 2024
·
4 min read
Drug Development
Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer’s Disease Pre-Clinical Treatment with HT-ALZ
Hoth Therapeutics, Inc. (NASDAQ: HOTH), is pleased to unveil positive pre-clinical research showcasing the potential of HT-ALZ, an innovative Alzheimer’s disease therapeutic.
March 19, 2024
·
5 min read
Press Releases
Hoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment Study
October 29, 2024
·
5 min read
Press Releases
Hoth Therapeutics Announces Promising Preclinical Results for Alzheimer’s Drug HT-ALZ
September 17, 2024
·
5 min read
Business
Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio
Hoth Therapeutics, Inc. today announced that it will continue its work with Venable, LLP to develop and protect its intellectual property.
February 29, 2024
·
4 min read
1 of 26,294
Next
